Search

Your search keyword '"Sven, Wach"' showing total 83 results

Search Constraints

Start Over You searched for: Author "Sven, Wach" Remove constraint Author: "Sven, Wach" Topic cancer research Remove constraint Topic: cancer research
83 results on '"Sven, Wach"'

Search Results

1. MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer

2. Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts

3. Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer

4. Co-staining of microRNAs and their target proteins by miRNA in situ hybridization and immunohistofluorescence on prostate cancer tissue microarrays

5. Endogenous Retroviral–K Envelope Is a Novel Tumor Antigen and Prognostic Indicator of Renal Cell Carcinoma

6. PIWI-Like 1 and PIWI-Like 2 Expression in Breast Cancer

7. Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy

8. Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo

9. CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma

10. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

11. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

12. High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer

13. Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma

14. Bladder tumor subtype commitment occurs in carcinoma in-situ driven by key signaling pathways including ECM remodeling

15. A new semisynthetic cardenolide analog 3β-[2-(1-amantadine)- 1-on-ethylamine]-digitoxigenin (AMANTADIG) affects G2/M cell cycle arrest and miRNA expression profiles and enhances proapoptotic survivin-2B expression in renal cell carcinoma cell lines

16. HLA-E expression and its clinical relevance in human renal cell carcinoma

17. Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma

18. Abstract 4327: Progranulin (GP88) is an independent prognostic factor for prostate cancer patients

19. Abstract PR04: Tumor immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes

20. Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder:A Retrospective Analysis of Two Independent Cohorts

21. MP61-10 PROGNOSTIC ROLE OF FGFR ALTERATIONS AND FGFR MRNA EXPRESSION IN METASTATIC UROTHELIAL CANCER TREATED WITH ANTI-PD(L1) INHIBITORS IN FIRST AN SECOND LINE SETTING

22. The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes

23. Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab

24. Abstract 3700: Association of the G/G-SNP309 variant in the mdm2 gene with earlier tumor onset in female renal cell carcinoma patients

25. The Immune Landscape of Cancer

26. mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma

27. Pan-cancer analysis of lncRNA regulation supports their targeting of cancer genes ineach tumor context

28. Genomic and functional approaches to understanding cancer aneuploidy

29. A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily

30. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

31. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas

32. The combined serum levels ofmiR-375and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer

33. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

34. Comprehensive molecular characterization of muscle invasive bladder cancer

35. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

36. Tumor immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes

37. High coexpression ofCCL2andCX3CL1is gender-specifically associated with good prognosis in soft tissue sarcoma patients

38. sE-cadherin is upregulated in serum of patients with renal cell carcinoma and promotes tumor cell dissemination in vitro

39. MicroRNA profiles classify papillary renal cell carcinoma subtypes

40. Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes

41. Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer

42. Expression of microRNA 210 associates with poor survival and age of tumor onset of soft-tissue sarcoma patients

43. Downregulation of Sec23A Protein by miRNA-375 in Prostate Carcinoma

44. MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening

45. Das plasmazytoide und mikropapilläre Urothelkarzinom

46. The plasmacytoid carcinoma of the bladder-rare variant of aggressive urothelial carcinoma

47. lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer

48. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

49. The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing

50. Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls

Catalog

Books, media, physical & digital resources